Gender

Non-Tricyclic Antidepressants Other Than monoamine oxidase inhibitor (MAOI) (Sleep Heart Health Study Visit One (SHHS1)) vs Sleep Heart Health Study (SHHS) Visit Number
Visit 1 Interim Follow-up Visit Visit 2 CVD Outcomes
Total 5,804 - - -
No 5,508 - - -
Yes 278 - - -
Unknown 18 - - -
Non-Tricyclic Antidepressants Other Than monoamine oxidase inhibitor (MAOI) (Sleep Heart Health Study Visit One (SHHS1)) vs Age at Sleep Heart Health Study Visit One (SHHS1)
Visit 1
35-44 years 45-54 years 55-64 years 65-74 years 75-84 years 85 years or older Total
Total 342 1,017 1,769 1,617 955 104 5,804
No 315 950 1,667 1,563 914 99 5,508
Yes 21 63 99 52 38 5 278
Unknown 6 4 3 2 3 - 18
Non-Tricyclic Antidepressants Other Than monoamine oxidase inhibitor (MAOI) (Sleep Heart Health Study Visit One (SHHS1)) vs Gender of the participant
Visit 1
Male Female Total
Total 2,765 3,039 5,804
No 2,664 2,844 5,508
Yes 90 188 278
Unknown 11 7 18
Non-Tricyclic Antidepressants Other Than monoamine oxidase inhibitor (MAOI) (Sleep Heart Health Study Visit One (SHHS1)) vs Race of the participant
Visit 1
White Black Other Total
Total 4,907 515 382 5,804
No 4,649 492 367 5,508
Yes 248 18 12 278
Unknown 10 5 3 18